Friday, October 11, 2024

Fw: Ref.: (LML) Infolep monthly overview of new publications on leprosy. October, 2024

 
Leprosy Mailing List – October 11,  2024

Ref.:  (LML) Infolep monthly overview of new publications on leprosy. October, 2024

From:  Roos Geutjes, Sophie Vissers and Upasana Regmi, Amsterdam, the Netherlands



Dear colleagues, 

We are thrilled to congratulate Jordan on becoming the first country to receive WHO verification for eliminating leprosy—a monumental achievement in global health!


In addition, we are proud to celebrate the recent launch of the InfoNTD e-learning platform, which took place at the NNN conference in Kuala Lumpur this October. The platform, connected to Infolep and InfoNTD, offers various courses such as Leprosy Reactions and SDR-PEP—don't forget to explore these valuable resources.

This month's newsletter brings you a wealth of exciting updates:

  • Research highlights: Including systematic reviews on drug resistance, publications on mental health, and stigma, as well as the latest WHO Weekly Epidemiological Record (2023) on leprosy.
  • Practical materials: Featuring resources on participatory health research, community engagement, and social and behavior change in NTD programs, developed by WHO and the NNN WASH working group.
  • Upcoming events: Such as the 22nd International Leprosy Congress in Bali, along with other key leprosy-related events.
  • Insightful case studies: Showcasing rare manifestations of leprosy, including neuropathies, drug reactions, and innovative treatment approaches.

Lastly, we are delighted to welcome Upasana Regmi to the InfoNTD and Infolep team as an interim support officer. At the same time, we say farewell to Sophie Vissers, who will be transitioning out of her role. We thank Sophie for her outstanding contributions and wish her all the best in her future endeavors.


Warm regards,


Roos Geutjes, Sophie Vissers and Upasana Regmi

www.infolep.org
info@infolep.org





Practical Materials



Reactions in Leprosy [E-learning infoNTD; Online Course] 


Post-exposure chemoprophylaxis for leprosy - SDR-PEP [E-learning infoNTD; Online Course] 


An Introduction and Practical Guide to Community Engagement and Involvement in Global Health Research  [National Institute for Health and Care Research, MESH Community Engagement Network; Online Course] 


Skin and Migration: Training for national, district-level, and front-line health workers [World Health Organization, 2024; Online Course] 


Atopic dermatitis with focus on Sub-Saharan Africa: Training for national and district-level health workers [World Health Organization, 2024; Online Course] 


Participatory health research and action: A practical guide on designathons [WHO, 2024; Guidelines] 


Community engagement in WHO guideline development [WHO, 2024; Guidelines] 


Social and behavior change in NTD programs [NNN Wash Working Group, 2024; Guideliones] 






Highlighted Publications



Leprosy: Jordan becomes first country to eliminate disease 
Wise J. BMJ. BMJ. 2024. 


Weekly epidemiological record- Global leprosy (Hansen disease) update, 2023: Elimination of leprosy disease is possible- Time to act!  
World Health Organization. 2024.


Self-healing in leprosy: A systematic review 
Stuetzle SCW, Bonkass A, van Brakel WH, et al. PLOS Neglected Tropical Diseases. Public Library of Science (PLoS). 2024; 18 (9): 1-10. 


Interventions to Reduce Skin-related Self-stigma: A Systematic Review.  
Traxler J, Stuhlmann C, Graf H, et al. Acta dermato-venereologica. 2024. 


Implications of drug resistance in leprosy: disease course, reactions and the use of novel drugs  
Sardana K, Muddebihal A, Scollard DM, et al. International Journal of Dermatology. Wiley. 2024. 


Review of research progress on different modalities of Macrophage death in Mycobacterium leprae infection.  
Jiang Y, Zou Y, Wang H. International immunopharmacology. 2024. 


Pure neuritic leprosy: Latest advancements and diagnostic modalities 
Razdan N, V B, Sadhu S. Diagnostic Microbiology and Infectious Disease. Elsevier BV. 2024. 






New publications


Feel free to contact us to receive full-text versions if these cannot be found through the Infolep portal.



The role of neurologists in the WHO "Toward Zero Leprosy" strategy
Klevor R, El-Sadig SM, Hassane DS, et al. Leprosy Review. Lepra. 2024; 95 (3): 1-3.


Spatial Model of Geographic Distribution of Leprosy Cases in East Java Province, Indonesia 
Makful M, Handayani Y, Nugraha F. Unnes Journal of Public Health. 2024. 


Cellular and molecular determinants of bacterial burden in leprosy granulomas revealed by single-cell multimodal omics 
Mi Z, Wang Z, Wang Y, et al. eBioMedicine. Elsevier BV. 2024. 


The fight against leprosy and lessons for the future: Commemorating the 50th anniversary of the Sasakawa Health Foundation 
Nanri T. Leprosy Review. Lepra. 2024; 95 (3): 1-4.  


Case reports on leprosy 
Nascimento DCD, Laguiche LD. Hansenologia Internationalis: hanseníase e outras doenças infecciosas. Instituto Lauro de Souza Lima. 2024. 


Cranial nerve palsies in leprosy: a systematic review of published case reports and case series  
Garg RK, Jain P, Suvirya S, et al. Acta Neurologica Belgica. Springer Science and Business Media LLC. 2024. 


Correlation of Dermatoscopic Findings in Leprosy with Clinical Spectrum and Histopathology: A Prospective Observational Study 
Chenganasseri SH, Kapilavayi S, Divya B, et al. Indian Journal of Leprosy. 2024. 


Anemia on Chronic Disease in Leprosy Before and After Completing Multi Drug Therapy 
Setyawati NK, Rusyati LMM, Indira IGAAE, et al. Eduvest - Journal of Universal Studies. Green Publisher. 2024; 4 (9) : 8409-8417.  


In Silico Investigation of the Constituents of Aroeira Honey (Astronium urundeuva) and the Binding Affinity with Important Proteins of M. leprae and M. tuberculosis  
de Souza VMM, do N. Costa GE, dos S. Silva RF, et al. Molecular Modeling Connect. Scifiniti Publishing. 2024; 1 (1) : 1-24.  


High-risk spatiotemporal patterns of leprosy in the southeastern region of Yunnan province from 2010 to 2022: an analysis at the township level 
Qiao L, Zhang C, Zhang M, et al. BMC Public Health. Springer Science and Business Media LLC. 2024; 24 (1) : 1-12. 


Role of histopathological, serological and molecular findings for the early diagnosis of treatment failure in leprosy 
de Carvalho Dornelas B, da Costa WVT, de Abreu JPF, et al. BMC Infectious Diseases. Springer Science and Business Media LLC. 2024; 24 (1) : 1-13. 


Investigation of community knowledge, attitudes and stigma towards leprosy in Nigeria: a mixed-methods study 
Murphy-Okpala N, Dahiru T, Eze C, et al. Transactions of The Royal Society of Tropical Medicine and Hygiene. Oxford University Press (OUP). 2024; 118 (10) : 697-709. 


Factors that Influenced and Delayed Self-reporting and Registration of Leprosy Affected People in Different Prevalence Areas of Bangladesh 
Hossain QZ, Boiragee J, Azad-Uz-Zaman Q, et al. Indian Journal of Leprosy. 2024. 


Atuação da equipe multiprofissional ao paciente sob tratamento hansênico na promoção da qualidade de vida 
Nascimento VFF, Silva RPDC, Araújo GSSD, et al. Revista Eletrônica Acervo Saúde. Revista Eletronica Acervo Saude. 2024. 


Estratégias de enfrentamento, limitação de atividades diárias e participação social de idosos que têm ou tiveram hanseníase 
Oliveira GTRD, Boconcelo I, Nardi SMT, et al. Revista Brasileira em Promoção da Saúde. Fundacao Edson Queiroz. 2024. 


Direitos, deveres e a realidade do estigma na hanseníase 
Silva VAMD, Souza DGPD, Santos WEAD, et al. Contribuciones A Las Ciencias Sociales . South Florida Publishing LLC. 2024; 17 (9) : 1-21. 


Análise do impacto da hanseníase na qualidade de vida de pacientes do estado de mais incidência do nordeste brasileiro 
Batista MRV, Cruz CND, Aragão FBA, et al. CONTRIBUCIONES A LAS CIENCIAS SOCIALES. South Florida Publishing LLC. 2024; 17 (9): 1-28.



Neglect of mental health issues and lack of integration of psychosocial interventions in Zero Leprosy Roadmaps: A critical oversight 
Fastenau A, Montague-Cardoso K. PLOS Mental Health. Public Library of Science (PLoS). 2024. 


Leprosy in Brazil: an analysis of the Global Burden of Disease estimates between 1990 and 2019 
de Araújo V, Veloso G, Kerr L, et al. Public Health. Elsevier BV. 2024. 


Interdisciplinary perspectives on 'what matters most' in the cultural shaping of health-related stigma in Indonesia  
Santosa A, Sopamena Y, Visser M, et al. BMJ Global Health. BMJ. 2024; 9 (9): 1-9.  


Dapsone-induced haemolysis among leprosy patients on MDT from an endemic area of central India 
Naik KP, Ganguly S, Shukla AK, et al. Journal of Family Medicine and Primary Care. Medknow. 2024. 


Global patterns of syphilis, gonococcal infection, typhoid fever, paratyphoid fever, diphtheria, pertussis, tetanus, and leprosy from 1990 to 2021: findings from the Global Burden of Disease Study 2021. 
Chen W, Chen Y, Cheng Z, et al. Infectious diseases of poverty. 2024; 13 (1): 1-23.   


Insights of infected Schwann cells extinction and inherited randomness in a stochastic model of leprosy.  
Ghosh S, Rana S, Mukherjee S, et al. Mathematical biosciences. 2024. 


Experiences of Patients Living in a Unique Leprosy Hospice in Greece: An Interpretative Phenomenological Analysis.  
Nikoloudi M, Bogdani E, Tsatsou I, et al. Cureus. 2024; 16 (8) : 1-11.  


Assessment of disability among leprosy patients on treatment initiation in kwale and kilifi counties, Kenya 
Karugu M, Njoroge M, Matu S, et al. East African Medical Journal . 2024. 


A review on leprosy: Etiology, epidemiology, pathophysiology, risk factors, differential diagnosis, management strategies and treatment modalities  
Tanwar P, Naagar M, Maity MK. International Journal of Pharmaceutical Research and Development. Comprehensive Publications. 2024; 6 (2) : 39-48. 


Leprosy in the Modern Age: clinical diagnosis and challenges in the 21st Century 
Jaiswal B, Rajpurohit P, Munot Y, et al. International journal of therapeutic innovation. Medic Scientific. 2024. 


Healing of leprosy-associated chronic plantar wounds with a novel biomembrane containing latex proteins from Calotropis procera 
Nunes MO, Alencar NMN, Pontes MAA, et al. Brazilian Journal of Biology. FapUNIFESP (SciELO). 2024.


Molecular Identification of Mycobacterium leprae in the Leprosy Patients. 
Warka U, Hatta M, Muslich L, et al. International journal of mycobacteriology. 2024. 


Exploring the Utility of High-Resolution Ultrasonography and Color Doppler of Peripheral Nerves in Monitoring Response to Treatment in Leprosy Patients: A Prospective, Observational Study. 
Sharma A, Narang T, Prakash M, et al. The American journal of tropical medicine and hygiene. 2024. 


A Histopathological study of Leprosy on skin and peripheral nerves with clinical correlation 
P TK, Vahini G, Yaswant VMK. Chinese Journal of Evidence-Based Medicine. 2024. 


A Cross Sectional Study on Quality of Life among Leprosy Affected Persons in Hyderabad 
A Durga , Kusuma AK. Indian Journal of Public Health Research & Development. Institute of Medico-legal Publications Private Limited. 2024; 15 (4) : 30-34. 


Exhausted CD8 T cells and anti-inflammatory macrophages characterize lepromatous leprosy lesions 
Mayer-Barber KD, Barber DL, Via LE. eBioMedicine. 2024. 


Podhans: podcast de comunicação pública sobre hanseníase produzido a partir da escuta dos usuários do SUS 
Lima FCD, Oliveira-Costa MSD, Fernandes MFM. JCOM América Latina. 2024. 


Inovação aplicada ao Diagnóstico com QPCR e o Impacto Hostil do Estigma em Indivíduos portadores da Hanseníase 
Ferreira Neto AG, Dias HM, Rezende GDO. Revista Contemporânea. South Florida Publishing LLC. 2024; 4 (9) : 1-19. 






Case Reports

A Rare Cause of Pancytopenia From Lepromatous Leprosy Diagnosed in Bone Marrow Aspiration: A Bolt From the Blue 
Shine R, Amitkumar K, Ganapathy S, et al. Cureus. Springer Science and Business Media LLC. 2024. 


Exploring the therapeutic and prophylactic potential of bedaquiline in leprosy.  
Khera H, Narang T, Sharma A, et al. International journal of dermatology. 2024. 


Haemophagocytic lymphohistiocytosis secondary to disseminated histoplasmosis in a patient with leprosy.  
Mufarrih S, Lusby H, Watson P. BMJ case reports. 2024. 


Case Report: Leprosy Masquerading as Relapsing Polychondritis  
Goel R, Rashmi R, Ghosh D, et al. 2024. 


A rare case of pure neuritic leprosy with hereditary spherocytosis: implications for dapsone use 
Agrawal S, Borkar M, Deoke S. Leprosy Review. 2024. 


An Unusual Cutaneous Manifestation of Tuberculoid Spectrum in Leprosy  
Satish S, Fernandes S, Bhat RM, et al. Indian Journal of Leprosy. 2024. 


Managing a Case of Steroid Dependant Erythema Necroticans in a Severely Immune-compromised Patient: Case report 
Mishra S, Madhual S, Panda M. Indian Journal of Leprosy. 2024. 


Malignant transformation of a long-term ulcer in a patient with leprosy sequelae: a case report 
Santos AGED, Neto AAM. Jornal Vascular Brasileiro. 2024. 


Unveiling the nerve bumps in Hansen's arm and forearm  
Sugumar R, Gomathy B, Cannane S. Case Reports in Clinical Radiology. Scientific Scholar. 2024. 


Erythema nodosum leprosum in a patient with lepromatous leprosy: A case report 
Sunil Kumar S, Sivannan S, Balasubramaniyam S, et al. Journal of Acute Disease. Medknow. 2024; 13 (4) : 161-164. 


Fever of unknown origin, blood and cerebrospinal fluid involvement: a leprosy case report. 
Chen H, Jiang Y, Shi Y, et al. Frontiers in immunology. 2024.   


Análise dos casos de Hanseníase no Estado do Pará, Brasil 
Junio LFV, Carvalho RRX, Campos FJSS, et al. Revista Eletrônica Acervo Saúde. Revista Eletronica Acervo Saude. 2024. 


Eritema Nodoso Leproso: Reporte de un caso pediátrico tratado exitosamente con talidomida  
Delgado N, Forero JR, Pérez P, et al. Infectio, Revista de la Asociación Colombiana de Infectologia. 2024. 








News & Events



Jordan becomes first country to receive WHO verification for eliminating leprosy (WHO) 


Our new doctors have no clue about leprosy': experts sceptical of India's target to eliminate the disease by 2027 (The guardian)


Call for Proposals: Mental Health Award - Accelerating scalable digital mental health interventions 
This call will fund research to evaluate and further develop scalable digital interventions to advance early intervention in depression, anxiety and psychosis. Funding amount: £3 to 7 million per project. The application must be submitted by 17:00 GMT on the 5th of December 2024.


RSTMH Annual Meeting 2024
October 10-11, 2024; Coin Street Conference Centre, London, United Kingdom.
The 2024 Annual Meeting will bring together members, Fellows and supporters from around the world to share knowledge, hear about the latest research and ideas, and encourage new collaborations. The theme of the meeting  is 'Tropical Medicine and Global Health: Innovations and Challenges' with a focus on significant cross cutting issues affecting many disease areas and health challenges. Registration is open.


Disability-Led Futures for a Just World: DRF's Path to 2029 
October 29; 9:00-10:00 EDT; online 
Join the virtual event celebrating the launch of DRF's new brand and 5-year visionary strategic plan. Please register in advance. 


Conference on Neglected Tropical Diseases 2024
May 2025; Nairobi, Kenya.
The 1st edition of the Conference on Neglected Tropical Diseases, organized by AME is tentatively scheduled in May 2025 in Nairobi, Kenya, as a hybrid meeting. The abstract-driven conference proposes a platform to disseminate new advancements, real-world data, implementation challenges, and novel governing models to discuss and generate solutions for cross-cutting topics and ultimately reduce the disease burden and societal impact of NTDs. This proposal supports the progress in foundational pillars of the WHO Roadmap by facilitating evidence-based program implementation, leveraging the cross-cutting approach, and providing a forum to discuss a paradigm shift toward country ownership of elimination programs.



WHO's goodwill ambassador Yohei Sasakawa urges for collaboration to eliminate leprosy (Himalayan Times)


Call for Proposals: NHIR Global Health Research - Researcher-led funding call bands 1 to 3
GHR – Researcher-led funds research that aims to improve health outcomes for the most vulnerable people in low and middle income countries (LMICs). Research must address evidence needs that are locally identified and prioritised, and must promote health equity, aligning with the aims of Sustainable Development Goal 3. Funding ranges from £250,000 to 7 million over a period up to 5 years depending on the band of application. 
Please check out the website for all eligibility criteria. Deadline for applications is 6th of November, 2024.


World Health Summit 2024
October 13-15, 2024; Berlin, Germany; hybrid event.
The theme of the conference is: "Building Trust for a Healthier World". You can join the event online live from all around the world for free and without any registration required. Simply click on the session of your interest in the
program and get the broadcasting link. Registration is open for on-site participation. Digital participation is possible through YouTube.


Tropical Infectious Diseases Gordon Research Conference
February 2-7, 2024; Renaissance Tuscany Il Ciocco, Lucca, Italy
The theme of the conference is "Basic and Clinical Research Strategies for Tackling Tropical Infectious Diseases in a Globalized World". Registration is open and deadline is January 5, 2025.


Global Disability Summit 2025 
April 2-4, 2025; Berlin, Germany. 
The Global Disability Summit aims to galvanize global efforts to realize disability inclusion around the world. It is a mechanism bringing together a wide variety of high-level stakeholders, engaging and discussing the progress in disability inclusion: governments, multilateral agencies, the private sector, academia and civil society organizations, organizations of persons with disabilities, and foundations. 


22nd International Leprosy Congress (ILC) 
July 5-9, 2025; Bali Nusa Dua Convention Centra (BNDCC), Bali, Indonesia 
This year the 22nd International Leprosy Congress (ILC) will be held in Bali, Indonesia! The congress uphold the theme: "Towards a World with Zero Leprosy". The theme aims to enhance the evidence into the clinical care in leprosy early diagnosis and therapeutics in the global era and prepare to face the new perspective of dermatology practice. Abstract submission and early bird registration is open until November 30th.






Links



Info Hansen - A innovative hub for knowledge sharing about Hansen's Disease
 


ALLF - Official website of the Association des Léprologues de Langue Française
 


LML - Leprosy Mailing List - a free moderated email list that allows all persons interested in leprosy to share ideas, information, experiences and questions
 


InfoNTD - Information on cross-cutting issues in Neglected Tropical Diseases (NTDs)


ILEP newsletter archive


GPZL newsletter subscription


WHO Goodwill Ambassador's Leprosy Bulletin


Leprosy Review


Leprosy Review Repository (1928-2001)


Fontilles Revista de Leprología


Indian Journal of Leprosy


Hansenologia Internationalis


HARP - database of Hansen's Disease Antimicrobial Resistance Profiles




GDPR & the Infolep newsletter

 
New EU data protection regulations came into force on 25 May 2018. We have been reviewing our practices with regards to the GDPR, including our
privacy statement and mailing list.

Infolep sends out monthly e-mails with an overview of recent publications on leprosy and related issues. The purpose of this activity is to keep subscribers up to date.

Infolep will only process the data we have (names, email addresses) for the purpose of sending you the newsletter. We take your security seriously and will never share your contact details with anyone else.

You can
update your preferences or unsubscribe from this list at any time.




LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/f5d646cb-2807-44d6-b0cd-22e7ae35ae71n%40googlegroups.com.

No comments: